We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the medicines.ie website. Find out more

Bayer Limited

The Atrium, Blackthorn Road, Dublin 18,
Telephone: +353 1 2999 313
Fax: +353 1 2061 456
Patient Information Leaflet last updated on medicines.ie: 24/08/2017
PIL Yasminelle

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 24/08/2017 and displayed until Current
Reasons for adding or updating:
  • Change to section 2 - what you need to know - contraindications
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 3 - overdose, missed or forgotten doses
  • Change to section 6 - date of revision
Updated on 04/09/2015 and displayed until 24/08/2017
Reasons for adding or updating:
  • Change to drug interactions
  • Change to date of revision
Updated on 07/08/2015 and displayed until 04/09/2015
Reasons for adding or updating:
  • Change of manufacturer
  • Change to date of revision
Updated on 01/04/2015 and displayed until 07/08/2015
Reasons for adding or updating:
  • Change to date of revision
Updated on 16/01/2015 and displayed until 01/04/2015
Reasons for adding or updating:
  • Change to drug interactions
  • Change to improve clarity and readability
  • Addition of information on reporting a side effect.
Updated on 17/09/2014 and displayed until 16/01/2015
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contraindications
  • Change to side-effects
  • Addition of information on reporting a side effect.
Updated on 25/04/2013 and displayed until 17/09/2014
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contraindications
  • Change to information about pregnancy or lactation
  • Change to date of revision
Updated on 28/03/2012 and displayed until 25/04/2013
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 23/03/2012 and displayed until 28/03/2012
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 21/12/2011 and displayed until 23/03/2012
Reasons for adding or updating:
  • Change to further information section
  • Change to date of revision
Updated on 17/06/2011 and displayed until 21/12/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to date of revision
Updated on 04/02/2011 and displayed until 17/06/2011
Reasons for adding or updating:
  • Change to improve clarity and readability
Updated on 12/01/2011 and displayed until 04/02/2011
Reasons for adding or updating:
  • Change to improve clarity and readability
  • Change due to user-testing of patient information
Updated on 28/01/2010 and displayed until 12/01/2011
Reasons for adding or updating:
  • Change to MA holder contact details
Updated on 05/10/2009 and displayed until 28/01/2010
Reasons for adding or updating:
  • Change to drug interactions
  • Change due to harmonisation of PIL
Updated on 24/06/2008 and displayed until 05/10/2009
Reasons for adding or updating:
  • Change to marketing authorisation holder address
  • Change to name of manufacturer
Updated on 16/08/2006 and displayed until 24/06/2008
Reasons for adding or updating:
  • New PIL for new product

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   Drospirenone
   ethinylestradiol betadex clathrate